Premium
Schizophrenic thinking and neuroleptic dosage
Author(s) -
Puente Antonio E.,
Andersson Candace
Publication year - 1987
Publication title -
journal of clinical psychology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.124
H-Index - 119
eISSN - 1097-4679
pISSN - 0021-9762
DOI - 10.1002/1097-4679(198703)43:2<189::aid-jclp2270430205>3.0.co;2-#
Subject(s) - psychology , dose , mental state , psychosis , schizophrenia (object oriented programming) , clinical psychology , antipsychotic drug , drug treatment , psychiatry , medicine , antipsychotic
Three groups ( N = 60) of schizophrenics (with varying levels of chronicity and drug dosages) were administered the Whitaker Index of Schizophrenic Thinking, the Mini‐Mental State, and the Self‐Conscious Scale. The results indicated that no differences existed between the chronic and acute groups on the dependent measures. Furthermore, no significant differences emerged between 21 of the acute patients who were discharged and 9 patients of the acute group who were not discharged (follow‐up). No significant differences on any of the dependent measures were observed when subjects were grouped according to level of schizophrenic thinking and of neuroleptic dose. Also, no relationship between neuroleptic drug dosage and thinking for any of the three groups was observed.